ONC vs TEVA
BeOne Medicines Ltd. (ONC) and Teva Pharmaceutical Industries Ltd (TEVA) are both filed with the SEC under Pharmaceutical Preparations. ONC is 12.6× TEVA's size by market cap ($550.6B against $43.8B); ONC trades at the higher fiscal-year P/E (1960.5× against 31.1×); TEVA reports the higher net margin (8.2% against 5.4%); ONC grew sales faster over three years (+55.7% against +5.0%); and over the past year TEVA returned +102.0% against ONC's +23.1%.
| ONC | TEVA | |
|---|---|---|
| Last close | $366.73 | $36.44 |
| Market cap | $550.6B | $43.8B |
| P/E (FY) | 1960.5× | 31.1× |
| P/S | 103.0× | 2.5× |
| EV/EBITDA | 929.1× | 13.3× |
| Gross margin | 87.5% | 51.8% |
| Operating margin | 8.4% | 12.5% |
| Net margin | 5.4% | 8.2% |
| Return on equity | 7.5% | 21.2% |
| Sales growth (3y) | +55.7% | +5.0% |
| 1-year return | +23.1% | +102.0% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both.
Who holds them, and who has traded them
| ONC | TEVA | |
|---|---|---|
| Institutional holders (13F) | 280 | 649 |
| Insider buyers − sellers (180d) | -5 | -5 |
| Congressional trades disclosed (180d) | 0 | 1 |
| Executive-branch officials on file — trades disclosed (180d) | 0 | 0 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
ONC vs TEVA: common questions
- Is ONC bigger than TEVA?
- ONC carries the larger market cap — $550.6B against $43.8B, both struck on 2026-08-27.
- Which trades at a higher P/E, ONC or TEVA?
- ONC, at a fiscal-year 1960.5× against 31.1× for TEVA. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have ONC and TEVA performed over the past year?
- TEVA returned +102.0% and ONC +23.1%, measured on the trailing calendar year to the last close.
- How many institutions hold ONC and TEVA?
- 280 13F filers report a position in ONC and 649 in TEVA, on the latest quarter in the panel.
- Are ONC and TEVA in the same industry?
- Both are filed with the SEC under Pharmaceutical Preparations, which is the classification this pairing is built on.
ONC overview → · TEVA overview → · ONC institutional ownership → · TEVA institutional ownership → · Congress and TEVA →
More in Pharmaceutical Preparations: ABBV vs ABT · ABBV vs ONC · ABBV vs REGN · ABBV vs TEVA
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/onc-vs-teva